# HARVEST MANAGEMENT LLC

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1140315. Source: https://holderbook.com/funds/1140315-harvest-management-llc/

- Reported value: $254.5M
- Positions: 55
- Weight of the ten largest: 74.6%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| ELECTRONIC ARTS INC | [EA](https://holderbook.com/stocks/EA/) | $40.9M | 199,500 | 16.1% | 4 |
| WARNER BROS DISCOVERY INC | [WBD](https://holderbook.com/stocks/WBD/) | $24.0M | 435,166 | 9.4% | 4 |
| TOPBUILD COR | [BLD](https://holderbook.com/stocks/BLD/) | $18.6M | 43,692 | 7.3% | 1 |
| JANUS HENDERSON GROUP PLC | [JHG](https://holderbook.com/stocks/JHG/) | $18.2M | 349,500 | 7.1% | 2 |
| PENUMBRA INC | [PEN](https://holderbook.com/stocks/PEN/) | $18.2M | 57,487 | 7.1% | 2 |
| TAYLOR MORRISON HOME CORP | [TMHC](https://holderbook.com/stocks/TMHC/) | $18.1M | 252,500 | 7.1% | 1 |
| NORFOLK SOUTHN CORP | [NSC](https://holderbook.com/stocks/NSC/) | $15.8M | 50,300 | 6.2% | 4 |
| NUVALENT INC | [NUVL](https://holderbook.com/stocks/NUVL/) | $13.1M | 36,000 | 5.1% | 1 |
| BIO-TECHNE CORP | [TECH](https://holderbook.com/stocks/TECH/) | $12.0M | 170,000 | 4.7% | 1 |
| CHART INDS INC | [GTLS](https://holderbook.com/stocks/GTLS/) | $11.1M | 53,000 | 4.4% | 1 |
| APOGEE THERAPEUTICS INC | [APGE](https://holderbook.com/stocks/APGE/) | $10.5M | 79,000 | 4.1% | 1 |
| CATALYST PHARMACEUTICALS INC | [CPRX](https://holderbook.com/stocks/CPRX/) | $4.7M | 150,000 | 1.9% | 1 |
| PARAMOUNT SKYDANCE CORP | [PSKY](https://holderbook.com/stocks/PSKY/) | $4.3M | 282,795 | 1.7% | 4 |
| SKYWATER TECHNOLOGY INC | [SKYT](https://holderbook.com/stocks/SKYT/) | $4.0M | 115,288 | 1.6% | 2 |
| WEBSTER FINL CORP | [WBS](https://holderbook.com/stocks/WBS/) | $3.5M | 46,100 | 1.4% | 2 |
| SILA REALTY TRUST INC | [SILA](https://holderbook.com/stocks/SILA/) | $3.2M | 105,900 | 1.3% | 1 |
| QXO INC | [QXO](https://holderbook.com/stocks/QXO/) | $2.4M | 0 | 1.0% | 1 |
| BEAZER HOMES USA INC | [BZH](https://holderbook.com/stocks/BZH/) | $2.2M | 80,000 | 0.9% | 1 |
| LIVERAMP HLDGS INC | [RAMP](https://holderbook.com/stocks/RAMP/) | $2.2M | 30,000 | 0.9% | 1 |
| ORGANON &amp; CO | [OGN](https://holderbook.com/stocks/OGN/) | $2.2M | 158,800 | 0.8% | 1 |
| MGM RESORTS INTERNATIONAL | [MGM](https://holderbook.com/stocks/MGM/) | $2.0M | 42,000 | 0.8% | 1 |
| TWO HARBORS INVENTMENT CORPO | [TWO](https://holderbook.com/stocks/TWO/) | $1.8M | 141,573 | 0.7% | 2 |
| UNIFIRST CORP MASS | [UNF](https://holderbook.com/stocks/UNF/) | $1.6M | 6,071 | 0.6% | 2 |
| BIOLIFE SOLUTIONS INC | [BLFS](https://holderbook.com/stocks/BLFS/) | $1.5M | 32,000 | 0.6% | 1 |
| REVOLUTION MEDICINES INC | [RVMD](https://holderbook.com/stocks/RVMD/) | $1.4M | 7,221 | 0.5% | 2 |
| IONQ INC | [IONQ](https://holderbook.com/stocks/IONQ/) | $1.3M | 0 | 0.5% | 1 |
| CAESARS ENTERTAINMENT INC NE | [CZR](https://holderbook.com/stocks/CZR/) | $1.3M | 44,000 | 0.5% | 1 |
| AVANOS MED INC | [AVNS](https://holderbook.com/stocks/AVNS/) | $1.2M | 47,600 | 0.5% | 1 |
| PAYONEER GLOBAL INC | [PAYO](https://holderbook.com/stocks/PAYO/) | $1.2M | 145,000 | 0.5% | 1 |
| CYTOKINETICS INC | [CYTK](https://holderbook.com/stocks/CYTK/) | $1.1M | 12,400 | 0.4% | 11 |
| CECO ENVIRONMENTAL CORP | [CECO](https://holderbook.com/stocks/CECO/) | $927.2K | 10,218 | 0.4% | 2 |
| NCR ATLEOS CORPORATION | [NATL](https://holderbook.com/stocks/NATL/) | $868.2K | 20,000 | 0.3% | 1 |
| ROKU INC | [ROKU](https://holderbook.com/stocks/ROKU/) | $828.8K | 6,000 | 0.3% | 1 |
| REPLIGEN CORP | [RGEN](https://holderbook.com/stocks/RGEN/) | $723.1K | 0 | 0.3% | 1 |
| ABIVAX SA | [ABVX](https://holderbook.com/stocks/ABVX/) | $706.3K | 2,800 | 0.3% | 1 |
| SILICON MOTION TECHNOLOGY CO | [SIMO](https://holderbook.com/stocks/SIMO/) | $643.3K | 1,930 | 0.3% | 4 |
| ESPERION THERAPEUTICS INC NE | [ESPR](https://holderbook.com/stocks/ESPR/) | $632.0K | 200,000 | 0.2% | 1 |
| NVIDIA CORPORATION | [NVDA](https://holderbook.com/stocks/NVDA/) | $506.8K | 2,533 | 0.2% | 8 |
| VIAVI SOLUTIONS INC | [VIAV](https://holderbook.com/stocks/VIAV/) | $465.4K | 9,747 | 0.2% | 2 |
| COMMVAULT SYS INC | [CVLT](https://holderbook.com/stocks/CVLT/) | $453.5K | 3,200 | 0.2% | 1 |
| STELLAR BANCORP INC | [STEL](https://holderbook.com/stocks/STEL/) | $416.7K | 10,598 | 0.2% | 2 |
| ALPHABET INC | [GOOG](https://holderbook.com/stocks/GOOG/) | $409.9K | 1,160 | 0.2% | 1 |
| BOEING CO | [BA](https://holderbook.com/stocks/BA/) | $389.6K | 1,800 | 0.2% | 3 |
| SUPERNUS PHARMACEUTICALS | [SUPN](https://holderbook.com/stocks/SUPN/) | $376.7K | 8,100 | 0.1% | 4 |
| LIGAND PHARMACEUTICALS INC | [LGND](https://holderbook.com/stocks/LGND/) | $347.7K | 1,100 | 0.1% | 1 |
| SELECT MED HLDGS CORP | [SEM](https://holderbook.com/stocks/SEM/) | $346.7K | 21,000 | 0.1% | 3 |
| ON SEMICONDUCTOR CORP | [ON](https://holderbook.com/stocks/ON/) | $330.9K | 3,500 | 0.1% | 1 |
| DOMINION ENERGY INC | [D](https://holderbook.com/stocks/D/) | $273.2K | 4,000 | 0.1% | 1 |
| NEUROCRINE BIOSCIENCES INC | [NBIX](https://holderbook.com/stocks/NBIX/) | $272.5K | 1,617 | 0.1% | 1 |
| ANALOG DEVICES INC | [ADI](https://holderbook.com/stocks/ADI/) | $270.5K | 681 | 0.1% | 2 |
| INHIBRX BIOSCIENCES INC | [INBX](https://holderbook.com/stocks/INBX/) | $246.3K | 2,600 | 0.1% | 1 |
| HUNTSMAN CORP | [HUN](https://holderbook.com/stocks/HUN/) | $159.3K | 15,000 | 0.1% | 1 |
| GEOPARK LTD | [GPRK](https://holderbook.com/stocks/GPRK/) | $152.9K | 16,800 | 0.1% | 3 |
| CERTARA INC | [CERT](https://holderbook.com/stocks/CERT/) | $131.0K | 20,000 | 0.1% | 1 |
| LUMEN TECHNOLOGIES INC | [LUMN](https://holderbook.com/stocks/LUMN/) | $96.3K | 12,540 | 0.0% | 21 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +4.4% | +14.8% | -10.5% | 67% |
| Q4 2025 | -4.4% | +2.4% | -6.8% | 61% |
| Q2 2025 | -6.6% | +10.5% | -17.1% | 62% |
| Q1 2025 | +1.5% | -4.6% | +6.0% | 71% |
| Q4 2024 | -1.3% | +2.1% | -3.5% | 62% |
| Q3 2024 | -1.9% | +5.4% | -7.3% | 80% |
| Q2 2024 | -2.2% | +4.0% | -6.2% | 71% |
| Q4 2023 | +0.4% | +11.2% | -10.8% | 71% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $254.5M | 55 |
| Q1 2026 | $206.4M | 49 |
| Q4 2025 | $312.0M | 54 |
| Q3 2025 | $231.3M | 52 |
| Q2 2025 | $235.0M | 48 |
| Q1 2025 | $226.4M | 50 |
| Q4 2024 | $207.1M | 46 |
| Q3 2024 | $196.7M | 44 |
| Q2 2024 | $131.0M | 42 |
| Q1 2024 | $148.3M | 37 |
| Q4 2023 | $108.1M | 38 |
| Q3 2023 | $192.3M | 42 |

